Redeye comments on Evaxion’s new AI-platform and strategic direction.
Måndag 27 mars 2023 annonserade Future Gaming att bolaget överenskommelser om återköp av obligatione...
Trifork A/S (”Trifork” or ”the Company”) is a Danish IT and business service provider operating in 6...
4C Group AB (”4C” eller ”Bolaget”) är en ledande leverantör av mjukvara och utbildning avseende orga...
NoHo Partners announced that it will acquire three well-known nightclubs in the Helsinki downtown ar...
Prostatype Genomics has proposed a SEK 34.3m funding (new issue of shares with preferential rights f...
Divio halverade rörelseförlusten under Q4. Kostnadskostymen sitter bra och nu växlar bolaget upp för...
Arcede har levererat viktiga framsteg kring kandidaten RCD405 mot primärt lungsjukdomen KOL.
NoHo Partners has signed an agreement in which ownership of three nightclubs in Helsinki downtown wi...
Redeye initiates coverage of Klaria Pharma Holding AB, a Swedish biotech company, utilising its tran...
Redeye has noted Dagens Medicin’s article and Plos One’s investigation regarding a ColdZyme study fr...
Redeye provides a research update on Lipum following the Q4 report published by the company earlier ...
Administer reports its H2/2022 results on March 30th.
Q-linea is in the early stage of its targeted European launch strategy.
För Alzinova stundar en spännande period då ny interimdata från Alzheimer-projektet ALZ-101 ska läsa...
Rovio’s Board of Directors today confirmed that the preliminary discussions with Playtika in connect...
Ökat fokus på affärsutveckling under 2022 och flera pågående diskussioner för licensavtal.
CoinShares International (CS) rapporterade en måttlig EBITDA-förlust på 6,5 miljoner GBP för FY22 (j...
Redeye gives a short comment on the announced rights issue and pauses its coverage.
2022 EBIT impacted by bad debt provisions of SEK 34m The provision relates to its Italian distributo...
